Systemic inflammation, with elevated markers such as C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), plays an important role in both, the progression of COPD and the development of insulin resistance. This evidence concerns the gene CRP and Insulin resistance.